SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Apricus Biosciences
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: eico20 who wrote (1358)7/1/2015 10:16:14 AM
From: Strong Long  Read Replies (1) of 2026
 
Eman, I do recall that the incidence of priapism was low with Vitaros. It was the mention of using it in the prescribed manner (no more than once daily and/or no more than 3 times a week) to mitigate the chances of developing priapism, that got my attention. I had assumed that the reason for such a limitation was based on the potential for skin irritation at the application site, but the reason given for the limitation in the 2 articles was to prevent the potential for priapism. I was trying to point to the notion that Vitaros, even as one little dab of cream, must be very potent, if that is their reason for the precaution. I view that as positive support that the skin permeation enhancer, and Vitaros as a whole, must work well.

Regarding Canada and the US, I'm placing my bets on Mexico first :)
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News